These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8793842)

  • 1. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.
    Anderson DA
    J Med Virol; 1987 May; 22(1):35-44. PubMed ID: 3035078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus.
    Cromeans T; Sobsey MD; Fields HA
    J Med Virol; 1987 May; 22(1):45-56. PubMed ID: 3035079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus.
    Krah DL; Amin RD; Nalin DR; Provost PJ
    J Infect Dis; 1991 Mar; 163(3):634-7. PubMed ID: 1847404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-antibody in situ enzyme immunoassay for infectivity titration of hepatitis A virus.
    Borovec S; Uren E
    J Virol Methods; 1997 Oct; 68(1):81-7. PubMed ID: 9395142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
    Hughes JV; Stanton LW
    J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
    Krah DL
    Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
    Binn LN; MacArthy PO; Marchwicki RH; Sjogren MH; Hoke CH; Burge JR; D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S102-5. PubMed ID: 1335636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and characteristics of cultured strains of hepatitis A virus from humans and monkeys].
    Korzaia LI; Shevtsova ZV; Lapin BA; D'iachenko AG; Krylova RI
    Vopr Virusol; 1997; 42(2):60-3. PubMed ID: 9182400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
    Yap KL; Lam SK
    J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemiluminescent focus assays for the quantitation of hepatitis A virus and rotavirus in cell cultures.
    Richards GP; Watson MA
    J Virol Methods; 2001 May; 94(1-2):69-80. PubMed ID: 11337041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The isolation and study of the characteristics of a cytopathic strain of the hepatitis A virus].
    Maĭdaniuk AG; Tiunnikov GI; Konakova VE; Bondarenko EP; Nemtsov IuV; Karpovich LG; Kalashnikova TV; Mamaeva NV; Sosnovtsev SV; Chizhikov VE
    Vopr Virusol; 1993; 38(3):101-5. PubMed ID: 8073747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of hepatitis A virus after ultra-violet inactivation.
    Wang CH; Tschen SY; Flehmig B
    Vaccine; 1995 Jun; 13(9):835-40. PubMed ID: 7483806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies].
    Karetnyĭ IuV; Andzhaparidze AG; Orlova TM; Balaian MS
    Vopr Virusol; 1989; 34(1):50-3. PubMed ID: 2543140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays.
    Lemon SM; Jansen RW
    J Virol Methods; 1985 Jun; 11(2):171-6. PubMed ID: 2991315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.